With a successful BRILACIDIN trial being reported soon, IPIX will become a healthy, valuable company. We will have the financial resources to fund the next phases of trials of KEVETRIN, LEADING TO GREAT SUCCESS in the long term. I'm not selling out for peanuts!
Know what you own.
gh